See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2020_Neubase_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 3149633, 'exp_sum': 0, 'exp_to_value': {'LiabilitiesCurrent': 0, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001173281, Neubase Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 11,029,235 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 145,833 |
| 2 | PropertyPlantAndEquipmentNet | 430,995 |
| 3 | remainder_Assets | 925,334 |
| 4 | LiabilitiesCurrent | 2,502,013 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,095,674 |
| 9 | ResearchAndDevelopmentExpense | 4,273,318 |
| 10 | remainder_Expenses | 13,589,255 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,531,397 |
| 1 | Liabilities | 2,502,013 |
| 2 | Expenses | 26,958,247 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,029,384 |
| 5 | NetIncome | -26,958,247 |
| 6 | ComprehensiveNetIncome | -26,958,247 |
| 7 | BaseVar | 20,995,828 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.678 |
| 9 | EconomicCapitalRatio | 1.36 |
Edgar->Model Mapping
Feature Distribution
